Coronavirus (COVID-19) Update
AmerisourceBergen and our global businesses are highly engaged during the ongoing spread of the novel COVID-19 “Coronavirus."
Read our latest update

Rare Diseases

Expertise supporting rare diseases

According to the National Institutes of Health (NIH), a disease is considered rare if it affects fewer than 200,000 individual in the United States. The NIH currently identifies roughly 7,000 diseases as rare or "orphan" diseases. Approximately 60% of all breakthrough therapies approved to by the Food and Drug Administration (FDA) are indicated for rare diseases. 

US Bioservices dispenses limited distribution and exclusive treatments for a number of rare diseases, for example: